Agennix Reports Results of FORTIS-M Phase III Trial With Talactoferrin Alfa in Non-Small Cell Lung Cancer

ABCDEFGHIJKLMNOPQRSTUVWXYZ




To view the detailed information, you need to SUBSCRIBE with us.

 screenshot